API prices have been under pressure over the past few quarters due to weak demand and competition from China in export ...

Medicare Advantage insurers are gearing up to convince lawmakers that the Biden administration’s policies have been detrimental to older Americans enrolled in the privately run alternative to Medicare ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good afternoon, everyone, and welcome to the Atea Pharmaceuticals Third Quarter 2024 Financial Results and Business Update Conference Call.

Cipla’s FDA-compliant facilities and its investments in US-based units place it in a strong position to weather potential ...

Drug shortages in the U.S. are increasing in number and duration, primarily affecting generic and multi-sourced drugs that ...

Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update. Clarity Pharmaceuticals has strengthened its production capabilities by signing ...

Evolving industry demands are driving the need for greater flexibility and innovation in processing equipment for ...

The additional recruitments will help the Drugs Controller General of India enforce good manufacturing practices for ...

Pharma player Granules India Limited on Friday said it has received an Establishment Inspection Report (EIR) from the US Food ...

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...

There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...

Granules India announced that it has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Unit V facility located at Jawaharlal Nehru Pharma ...